Home Cart 0 Sign in  
X

[ CAS No. 65181-78-4 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 65181-78-4
Chemical Structure| 65181-78-4
Chemical Structure| 65181-78-4
Structure of 65181-78-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 65181-78-4 ]

Related Doc. of [ 65181-78-4 ]

Alternatived Products of [ 65181-78-4 ]

Product Details of [ 65181-78-4 ]

CAS No. :65181-78-4 MDL No. :MFCD00144965
Formula : C38H32N2 Boiling Point : -
Linear Structure Formula :- InChI Key :OGGKVJMNFFSDEV-UHFFFAOYSA-N
M.W :516.67 Pubchem ID :103315
Synonyms :
UV :352 nm (in THF)
FL :398 nm (in THF) Materials Type :HTM

Calculated chemistry of [ 65181-78-4 ]

Physicochemical Properties

Num. heavy atoms : 40
Num. arom. heavy atoms : 36
Fraction Csp3 : 0.05
Num. rotatable bonds : 7
Num. H-bond acceptors : 0.0
Num. H-bond donors : 0.0
Molar Refractivity : 171.18
TPSA : 6.48 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -1.82 cm/s

Lipophilicity

Log Po/w (iLOGP) : 5.94
Log Po/w (XLOGP3) : 10.75
Log Po/w (WLOGP) : 10.91
Log Po/w (MLOGP) : 8.14
Log Po/w (SILICOS-IT) : 8.05
Consensus Log Po/w : 8.76

Druglikeness

Lipinski : 2.0
Ghose : None
Veber : 0.0
Egan : 1.0
Muegge : 1.0
Bioavailability Score : 0.17

Water Solubility

Log S (ESOL) : -10.02
Solubility : 0.0000000494 mg/ml ; 0.0000000001 mol/l
Class : Insoluble
Log S (Ali) : -10.84
Solubility : 0.0000000074 mg/ml ; 0.0 mol/l
Class : Insoluble
Log S (SILICOS-IT) : -14.23
Solubility : 0.0 mg/ml ; 0.0 mol/l
Class : Insoluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 3.45

Safety of [ 65181-78-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335-H351-H361 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 65181-78-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 65181-78-4 ]
  • Downstream synthetic route of [ 65181-78-4 ]

[ 65181-78-4 ] Synthesis Path-Upstream   1~16

  • 1
  • [ 92-86-4 ]
  • [ 1205-64-7 ]
  • [ 65181-78-4 ]
YieldReaction ConditionsOperation in experiment
85.2% With sodium t-butanolate In toluene at 20 - 130℃; Inert atmosphere 3.0 g (30 mmol) of sodium tert-butoxide, 217 mg (0.5 mmol) of IPr-HCl (compound No. 1), 45 mg (0.2 mmol) of palladium(II) acetate, 3.67 g (20 mmol) of 3-methyldiphenylamine, 3.2 g (10 mmol) of 4,4'-dibromobiphenyl and 30 ml of toluene were put into a 50-ml three-neck flask equipped with a stirrer, a condenser tube, a thermometer and a gas-introducing duct, in an argon current at room temperature, and reacted under reflux in an oil bath controlled at a temperature of 130°C for 7 hours. The reaction liquid was cooled to room temperature, then left overnight at room temperature, and 150 ml of methylene chloride was added thereto. The insoluble matter was removed by filtration, and the filtrate was washed twice with 50 ml of water. This was dewatered and dried with 30 g of anhydrous sodium sulfate, and the solvent was evaporated away to give a residue. The residue was purified through column chromatography (carrier, Fuji Silicia's NH silica gel 150 g; eluent, cyclohexane) to give 4.4 g of N,N'-diphenyl-N,N'-di(m-tolyl)benzidine (TPD) (yield 85.2percent).
51%
Stage #1: With sodium hydride; magnesium bromide In 5,5-dimethyl-1,3-cyclohexadiene at 140℃; for 2 h; Inert atmosphere
Stage #2: With iron(II) chloride In 5,5-dimethyl-1,3-cyclohexadiene at 140℃; for 14 h; Inert atmosphere
In a 100 ml flask purged with a nitrogen atmosphere,30 g of xylene, 7.33 g (40 mmol) of N- (3-methylphenyl) aniline, 0.96 g (40 mmol) of sodium hydride,7.36 g (40 mmol) of magnesium bromide was charged,The reaction solution was heated to 140 ° C. while stirring.After aging for 2 hours at the same temperature, 0.063 g (0.5 mmol) of iron (II) chloride,3.12 g (10 mmol) of 4,4'-dibromobiphenyl was added,Further aging was carried out for 14 hours at the same temperature. After completion of the reaction,After cooling, water was added to dissolve the salt and liquid separation was carried out. After separating the organic layer,As a result of analysis by GC using the internal standard method,Bis (3-methylphenylphenylamino) biphenyl as a target product was produced in a yield of 51percent.
Reference: [1] Tetrahedron Letters, 1998, vol. 39, # 16, p. 2367 - 2370
[2] Journal of the Chinese Chemical Society, 2001, vol. 48, # 6 A, p. 1059 - 1064
[3] Patent: EP2157077, 2010, A1, . Location in patent: Page/Page column 9-10
[4] Journal of the American Chemical Society, 2012, vol. 134, # 50, p. 20262 - 20265
[5] Patent: JP5777106, 2015, B2, . Location in patent: Paragraph 0037
[6] Chemical Communications, 2010, vol. 46, # 7, p. 1103 - 1105
[7] Chemistry - An Asian Journal, 2010, vol. 5, # 8, p. 1788 - 1795
  • 2
  • [ 351184-18-4 ]
  • [ 65181-78-4 ]
YieldReaction ConditionsOperation in experiment
80% With 3 A molecular sieve In N,N-dimethyl-formamide at 60 - 65℃; for 2.16667 - 5.25 h; Charge a dry, nitrogen filled flask with 4.9 g (0.07 mol of zinc powder), 3.4 g (0.01 mol) of triphenylphosphine. 0.4 g (0.002 mol) of 2,2'-bipyridyl, 0.3 g (0.002 mol) of anhydrous NiCl2, 30 mL of dry, deoxygenated DMF, and 2 g of activated 3A molecular sieves. The mixture is heated under nitrogen to 65° C. until the gray color changed to dark brown (about 10-15 minutes). Maintaining a pot temperature of 60° C., a solution of (4-chloro-phenyl)-phenyl-m-tolyl amine (13.4 g, 0.04 mol) in 40 mL of DMF is added dropwise. After addition is over, the reaction is stirred between 60-65° C. for 2-5 hours, until TLC analysis revealed complete consumption of starting aryl chloride. The reaction is diluted with dichloromethane, filtered to remove excess zinc and solids. The filtrate washed four times with water. The dichloromethane layer is dried over sodium sulfate, filtered and concentrated to a reduced volume. The dichloromethane solution is treated with silica gel, filtered, and solution is treated with neutral alumina until the solution is pale yellow. The product is crystallized twice to afford 8.7 g (80percent) of N4,N4'-diphenyl-N4,N4'-di-m-tolyl-biphenyl-4,4'- diamine as a white solid. An analytical sample can be obtained by chromatography using a slow gradient of 0-5percent ethyl acetate in hexane.
Reference: [1] Patent: US6407289, 2002, B1, . Location in patent: Page column 4
  • 3
  • [ 108-41-8 ]
  • [ 92-86-4 ]
  • [ 108-90-7 ]
  • [ 65181-78-4 ]
Reference: [1] Journal of the American Chemical Society, 2007, vol. 129, # 34, p. 10354 - 10355
  • 4
  • [ 870194-10-8 ]
  • [ 92-86-4 ]
  • [ 65181-78-4 ]
Reference: [1] Organic and Biomolecular Chemistry, 2005, vol. 3, # 20, p. 3767 - 3781
  • 5
  • [ 3001-15-8 ]
  • [ 1205-64-7 ]
  • [ 65181-78-4 ]
Reference: [1] Journal of Organic Chemistry, 1999, vol. 64, # 2, p. 670 - 674
[2] Patent: EP1553079, 2005, A2, . Location in patent: Page/Page column 11
  • 6
  • [ 3001-15-8 ]
  • [ 1205-64-7 ]
  • [ 620-84-8 ]
  • [ 20441-06-9 ]
  • [ 65181-78-4 ]
Reference: [1] Patent: JP2005/162671, 2005, A, . Location in patent: Page/Page column 11
[2] Patent: EP1553079, 2005, A2, . Location in patent: Page/Page column 11-12
  • 7
  • [ 92-86-4 ]
  • [ 1205-64-7 ]
  • [ 122-39-4 ]
  • [ 15546-43-7 ]
  • [ 65181-78-4 ]
Reference: [1] Patent: US2005/80292, 2005, A1, . Location in patent: Page/Page column 2
[2] Patent: US2005/80292, 2005, A1, . Location in patent: Page/Page column 4
[3] Patent: US2005/80292, 2005, A1, . Location in patent: Page/Page column 3
[4] Patent: US2005/80292, 2005, A1, . Location in patent: Page/Page column 3
[5] Patent: US2005/80292, 2005, A1, . Location in patent: Page/Page column 4
[6] Patent: US2005/80292, 2005, A1, . Location in patent: Page/Page column 4
[7] Patent: US2005/80292, 2005, A1, . Location in patent: Page/Page column 4
[8] Patent: US2005/80292, 2005, A1, . Location in patent: Page/Page column 4
[9] Patent: US2005/80292, 2005, A1, . Location in patent: Page/Page column 3
[10] Patent: US2005/80292, 2005, A1, . Location in patent: Page/Page column 3
  • 8
  • [ 591-17-3 ]
  • [ 108-90-7 ]
  • [ 92-87-5 ]
  • [ 65181-78-4 ]
Reference: [1] Journal of the American Chemical Society, 2010, vol. 132, # 45, p. 15914 - 15917
  • 9
  • [ 1205-64-7 ]
  • [ 65181-78-4 ]
Reference: [1] Organic and Biomolecular Chemistry, 2005, vol. 3, # 20, p. 3767 - 3781
  • 10
  • [ 3001-15-8 ]
  • [ 1205-64-7 ]
  • [ 12775-96-1 ]
  • [ 65181-78-4 ]
Reference: [1] Patent: US4764625, 1988, A,
  • 11
  • [ 4316-53-4 ]
  • [ 65181-78-4 ]
Reference: [1] Journal of Organic Chemistry, 2017, vol. 82, # 17, p. 8958 - 8972
  • 12
  • [ 3001-15-8 ]
  • [ 92115-21-4 ]
  • [ 65181-78-4 ]
Reference: [1] Patent: JP2005/162671, 2005, A, . Location in patent: Page/Page column 10
  • 13
  • [ 118-91-2 ]
  • [ 65181-78-4 ]
Reference: [1] Patent: CN108276300, 2018, A,
  • 14
  • [ 16524-22-4 ]
  • [ 65181-78-4 ]
Reference: [1] Patent: CN108276300, 2018, A,
  • 15
  • [ 108-44-1 ]
  • [ 65181-78-4 ]
Reference: [1] Patent: CN108276300, 2018, A,
  • 16
  • [ 625-95-6 ]
  • [ 531-91-9 ]
  • [ 65181-78-4 ]
Reference: [1] Journal of Physical Chemistry, 1984, vol. 88, # 20, p. 4707 - 4714
Same Skeleton Products
Historical Records